DOCS.L

Dr. Martens plc
Dr. Martens PLC - Confirmation of new CEO start date
28th November 2024, 07:01
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 9261N
Dr. Martens PLC
28 November 2024
 

 

28 November 2024

Dr. Martens plc

('Dr. Martens', 'the Company')

Confirmation of new CEO start date

 

Further to the Company's previous announcement on 16 April 2024 that Ije Nwokorie would succeed Kenny Wilson as its new Chief Executive Officer before the end of FY25, Dr. Martens is pleased to announce that Ije's appointment will take effect from 6 January 2025. The Company also confirms that Kenny Wilson will step down from the Board on that date. Kenny will remain available to Ije and the wider Global Leadership Team until 31 March 2025 to ensure a smooth handover.

In accordance with the Company's statutory obligations under section 430(2B) Companies Act 2006, details of Kenny Wilson's exit arrangements will be made available on the Company's corporate website, www.drmartensplc.com.

 

 

This announcement has been made in accordance with the requirements of paragraph 9.6.12 of the UK Listing Rules. The Company confirms that there is no further information required to be disclosed pursuant to paragraph 9.6.13 of the UK Listing Rules.

Enquiries

Investors and analysts                                                                  

Bethany Barnes, Director of Investor Relations                                                Bethany.Barnes@drmartens.com                                                                                                                                                                          +44 7825 187465

Beth Fionda, Investor Relations Manager                                                            Beth.Fionda@drmartens.com                                                                                                                                                                                 +44 203 995 2644

 

Press                                                                                                                                                   

H/Advisors Maitland                                                                                                       +44 207 379 5151

Katharine Spence                                                                                                            +44 7384 535739

 

Gill Hammond, Director of Communications                                                                 +44 7384 214248

 

About Dr. Martens

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Produced originally for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens has since transcended its working-class roots while still celebrating its proud heritage and, six decades later, "Docs" or "DM's" are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. The Company is a constituent of the FTSE 250 index.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAXFXALPLFFA]]>
TwitterFacebookLinkedIn